| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | — | — | — | — |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| — | — | — | — |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | — | — | — | — |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| — | — | — | — |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | — |
| Earnings | — | — | — |
| Book Value | — | — | — |
| Year |
|---|
| Year |
|---|
| Year |
|---|
| Year |
|---|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 9.94 | 9.99 | 10.51 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | 11.16 | 10.90 | 12.00 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Employees
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Gross Margin
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EBT
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EBT Margin
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Net Income
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Depreciation
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Earnings/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Shares
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PE Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PS Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PB Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EV/Sales
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EV/FCF
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
FCF
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Total Debt
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Net Debt
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Sh' Equity
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
ROA
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
ROIC
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
ROE
|
Andretti Acquisition Corp. II (POLE), a pre-merger SPAC, offers no operational fundamentals—no revenue, earnings, or cash flows—highlighting the inherent risks of blank-check companies that hold cash in trust but face redemption pressures and potential liquidation if no deal materializes by 2029. Tied to the Andretti racing legacy, it eyes motorsports or auto targets, but a failed Formula 1 bid and zero insider activity signal limited conviction amid a post-2021 SPAC bust that erased over 90% of values due to regulatory crackdowns.
Price projections for 2024-2026 cluster tightly around the recent $10 close, with narrow spreads (±5-6%) implying stability but stagnation, vulnerable to market volatility and opportunity costs versus steady performers like treasuries or the S&P 500. Absent balance sheet details on debt or equity, downside protection relies solely on trust assets, while merger risks loom large—historical post-de-SPAC underperformance averages 50-60%.
For risk-averse investors, POLE demands vigilance on extensions and redemptions, warranting just 1-2% portfolio allocation with hedges; its inertia underscores why proven compounders outperform in uncertain times. Read the full analysis for detailed projections, risks, and monitoring strategies.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.